These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 30773190)

  • 1. Addition of chemotherapy improves overall survival in patients with T2N0M0 non-small cell lung cancer undergoing definitive radiation therapy: An analysis of the SEER database.
    Komiya T; Chaaya G; Powell E
    Radiother Oncol; 2019 Feb; 131():75-80. PubMed ID: 30773190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the AJCC 8th lung cancer staging system among patients with small cell lung cancer.
    Abdel-Rahman O
    Clin Transl Oncol; 2018 Apr; 20(4):550-556. PubMed ID: 28808860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the prognostic value of new sub-stages within the AJCC 8th edition of non-small cell lung cancer.
    Abdel-Rahman O
    Clin Transl Oncol; 2017 Nov; 19(11):1414-1420. PubMed ID: 28497423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 7th and 8th editions of the UICC/AJCC TNM staging for non-small cell lung cancer in a non-metastatic North American cohort undergoing primary radiation treatment.
    Koul R; Rathod S; Dubey A; Bashir B; Chowdhury A
    Lung Cancer; 2018 Sep; 123():116-120. PubMed ID: 30089581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the external validity of the American Joint Committee on Cancer 8th staging system for anal carcinoma.
    Oweira H; Giryes A; Mannhart M; Decker M; Schlumpf R; Abdel-Rahman O
    Curr Med Res Opin; 2018 May; 34(5):923-929. PubMed ID: 29448859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of stage and clinical/prognostic factors for lung cancer from SEER registries: AJCC staging and collaborative stage data collection system.
    Chen VW; Ruiz BA; Hsieh MC; Wu XC; Ries LA; Lewis DR
    Cancer; 2014 Dec; 120 Suppl 23(0 0):3781-92. PubMed ID: 25412390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
    Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107
    [No Abstract]   [Full Text] [Related]  

  • 8. Challenging a dogma; AJCC 8th staging system is not sufficient to predict outcomes of patients with malignant pleural mesothelioma.
    Abdel-Rahman O
    Lung Cancer; 2017 Nov; 113():128-133. PubMed ID: 29110839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the 8th AJCC staging system for pathologically versus clinically staged pancreatic adenocarcinoma: A time to revisit a dogma?
    Abdel-Rahman O
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):64-69. PubMed ID: 29428107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
    Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
    Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the staging method on the prognostic utility of the 8th AJCC staging system for non-small-cell lung cancer.
    Abdel-Rahman O
    Future Oncol; 2017 Oct; 13(25):2277-2284. PubMed ID: 28976218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-evaluation of the prognostic value of visceral pleura invasion in Stage IB non-small cell lung cancer using the prospective multicenter ACOSOG Z0030 trial data set.
    Fibla JJ; Cassivi SD; Brunelli A; Decker PA; Allen MS; Darling GE; Landreneau RJ; Putnam JB
    Lung Cancer; 2012 Dec; 78(3):259-62. PubMed ID: 23040416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissecting the heterogeneity of stage III non-small-cell lung cancer through incorporation of grade and histology.
    Abdel-Rahman O
    Future Oncol; 2017 Dec; 13(30):2811-2821. PubMed ID: 29188724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of preoperative radiation on survival of patients with T3N0 >7-cm non-small cell lung cancers treated with anatomic resection using the Surveillance, Epidemiology, and End Results database.
    Moreno AC; Morgensztern D; Yu JB; Boffa DJ; Decker RH; Detterbeck FC; Kim AW
    J Surg Res; 2013 Sep; 184(1):10-8. PubMed ID: 23583079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of proton therapy and carbon-ion therapy for large (T2a-T2bN0M0) non-small-cell lung cancer.
    Iwata H; Demizu Y; Fujii O; Terashima K; Mima M; Niwa Y; Hashimoto N; Akagi T; Sasaki R; Hishikawa Y; Abe M; Shibamoto Y; Murakami M; Fuwa N
    J Thorac Oncol; 2013 Jun; 8(6):726-35. PubMed ID: 23459403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the prognostic value of the 8th AJCC staging system for patients with clinically staged prostate cancer; A time to sub-classify stage IV?
    Abdel-Rahman O
    PLoS One; 2017; 12(11):e0188450. PubMed ID: 29182656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the proposals of the international association for the study of lung cancer in the forthcoming edition of lung cancer staging system to predict long-term prognosis of operated patients.
    Rena O; Massera F; Robustellini M; Papalia E; Delfanti R; Lisi E; Pirondini E; Turello D; Casadio C
    Cancer J; 2010; 16(2):176-81. PubMed ID: 20404615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Matter of Comprehensive Informed Consent: Short-Term Mortality Rates With Definitive Treatment Options in Elderly Stage I NSCLC.
    Dalwadi SM; Savjani RR; Bernicker EH; Butler EB; Teh BS; Farach AM
    Am J Clin Oncol; 2019 Nov; 42(11):851-855. PubMed ID: 31573986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Radiation Therapy Oncology Group and American Joint Committee on Cancer staging systems among patients with non-small cell lung cancer receiving hyperfractionated radiation therapy. A report of the Radiation Therapy Oncology Group protocol 83-11.
    Curran WJ; Cox JD; Azarnia N; Byhardt RW; Shin KH; Emani B; Phillips TL; Selim H; Herskovic A; Mohiuddin M
    Cancer; 1991 Aug; 68(3):509-16. PubMed ID: 1648432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the 8th AJCC staging system for gastric cancer in a population-based setting.
    Abdel-Rahman O
    Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):525-530. PubMed ID: 29198151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.